Franklin, MA – Prestige Scientific is pleased to announce the successful completion of a Senior Medical Director search with our partner, a prominent international biopharmaceutical company whose scope encompasses the entire pharmaceutical value chain, from research and development to production and marketing.
The individual hired for this role is a board-certified ophthalmologist, physician-scientist, and clinical development physician with expertise spanning ophthalmology clinical development, lifecycle strategy, regulatory evidence generation, and real-world data analytics. Their background combines hands-on ophthalmology development experience with unique experience evaluating ophthalmic datasets and translating those insights into clinical and regulatory strategy.
This critical hire will be responsible for overseeing the strategic and operational execution of clinical programs across multiple trials and indications. This senior leader will provide high-level medical, scientific, and strategic input into clinical development plans, safety profiles, and regulatory submissions, ensuring alignment with therapeutic area strategy and corporate objectives. They will partner closely with executive leadership, regulatory authorities, key opinion leaders, and internal stakeholders to drive innovation, safeguard patient safety, and deliver successful clinical outcomes.
Prestige presented 3 individuals for this role, the hired candidate was presented on day one of the search, and the search was completed in 72 days. Congratulations to our search team for this successful project!
About Prestige Scientific:
Prestige Scientific is an executive search firm that advises our clients on recruiting impactful leaders. We provide our clients with a performance-based hiring system that identifies leaders with past success meeting similar corporate objectives as their own, while overcoming challenges and adhering to critical timelines. We have dedicated experts in eleven practice areas that mirror a typical biopharma company, allowing us to support our client's growth from Discovery through Commercial.
